GSA Capital Partners LLP Buys Shares of 89,433 Perrigo Company plc $PRGO

GSA Capital Partners LLP bought a new stake in shares of Perrigo Company plc (NYSE:PRGO) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund bought 89,433 shares of the company’s stock, valued at approximately $1,245,000.

A number of other hedge funds and other institutional investors also recently modified their holdings of the company. Envestnet Portfolio Solutions Inc. raised its stake in shares of Perrigo by 113.1% in the 4th quarter. Envestnet Portfolio Solutions Inc. now owns 38,402 shares of the company’s stock worth $535,000 after buying an additional 20,378 shares in the last quarter. Gamco Investors INC. ET AL raised its stake in shares of Perrigo by 26.0% in the 4th quarter. Gamco Investors INC. ET AL now owns 1,077,785 shares of the company’s stock worth $15,003,000 after buying an additional 222,287 shares in the last quarter. Gabelli Funds LLC raised its stake in shares of Perrigo by 17.9% in the 4th quarter. Gabelli Funds LLC now owns 688,048 shares of the company’s stock worth $9,578,000 after buying an additional 104,330 shares in the last quarter. Burford Brothers Inc. bought a new stake in shares of Perrigo in the 4th quarter worth $484,000. Finally, Oregon Public Employees Retirement Fund raised its stake in shares of Perrigo by 13.6% in the 4th quarter. Oregon Public Employees Retirement Fund now owns 31,500 shares of the company’s stock worth $438,000 after buying an additional 3,779 shares in the last quarter. Institutional investors own 95.91% of the company’s stock.

Perrigo Stock Performance

Shares of NYSE PRGO opened at $11.16 on Thursday. The company has a quick ratio of 1.59, a current ratio of 2.72 and a debt-to-equity ratio of 1.45. The stock has a market capitalization of $1.54 billion, a price-to-earnings ratio of -0.85, a PEG ratio of 1.24 and a beta of 0.52. The stock’s fifty day simple moving average is $10.78 and its 200 day simple moving average is $12.92. Perrigo Company plc has a 52-week low of $9.23 and a 52-week high of $28.43.

Perrigo (NYSE:PRGO) last issued its earnings results on Wednesday, May 6th. The company reported $0.43 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.39 by $0.04. The business had revenue of $841.80 million for the quarter, compared to analysts’ expectations of $1.04 billion. Perrigo had a positive return on equity of 9.96% and a negative net margin of 43.50%.The company’s quarterly revenue was down 7.2% on a year-over-year basis. During the same period in the previous year, the firm posted $0.60 EPS. Perrigo has set its FY 2026 guidance at 2.250-2.550 EPS. As a group, sell-side analysts forecast that Perrigo Company plc will post 2.14 earnings per share for the current fiscal year.

Perrigo Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 16th. Stockholders of record on Friday, May 29th will be issued a dividend of $0.29 per share. The ex-dividend date is Friday, May 29th. This represents a $1.16 dividend on an annualized basis and a dividend yield of 10.4%. Perrigo’s payout ratio is currently -8.85%.

Analyst Ratings Changes

A number of research firms have recently commented on PRGO. Canaccord Genuity Group dropped their price objective on Perrigo from $20.00 to $17.00 and set a “buy” rating on the stock in a research note on Friday, February 27th. Weiss Ratings raised Perrigo from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Wednesday, May 13th. Jefferies Financial Group reissued a “hold” rating on shares of Perrigo in a research note on Thursday, February 26th. Finally, Zacks Research upgraded Perrigo from a “strong sell” rating to a “hold” rating in a report on Monday, April 27th. One research analyst has rated the stock with a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $19.33.

Perrigo Company Profile

Perrigo Company plc is a global healthcare supplier specializing in over-the-counter (OTC) and self-care products, as well as generic prescription pharmaceuticals and active pharmaceutical ingredients. The company develops, manufactures and distributes a broad array of consumer health products, including analgesics, vitamins and supplements, digestive health remedies, topical treatments, and infant formulas. Perrigo’s focus on private-label solutions has made it a leading partner for retailers and pharmacy chains seeking high-quality, value-oriented alternatives to branded medications and health supplements.

Organized across three principal business segments—Consumer Healthcare, Prescription Pharmaceuticals and Active Pharmaceutical Ingredients—Perrigo’s operations span research and development, manufacturing, quality assurance and global distribution.